Search company, investor...

Progenika

progenika.com

Stage

Other Investors | Alive

About Progenika

Progenika, a newly formed U.S. company, is a spin-out from Progenika Biopharma, S.A., a Spanish biotech company that designs and develops tools for personalized medicine. The company develops and manufactures novel DNA Genotyping microarrays for the diagnosis and prognosis of human disease.

Headquarters Location

500 Technology Square 1St Floor

Cambridge, Massachusetts, 02139,

United States

617-500-5100

Missing: Progenika's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Progenika's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Progenika

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Progenika is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

295 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Progenika Patents

Progenika has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • Clusters of differentiation
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/12/2015

12/1/2020

Molecular biology, Genetics, DNA, Small nuclear RNA, Biotechnology

Grant

Application Date

8/12/2015

Grant Date

12/1/2020

Title

Related Topics

Molecular biology, Genetics, DNA, Small nuclear RNA, Biotechnology

Status

Grant

Latest Progenika News

FDA Approves Progenika MDx Assay for Blood Compatibility

Oct 11, 2018

NEW YORK (360Dx) – The US Food and Drug Administration announced after the close of the market on Thursday that it has approved a molecular assay to determine blood compatibility for blood transfusions. Progenika Biopharma's ID Core XT test can be used to determine blood donor and patient non-ABO red blood cell types, the FDA said, adding it is the second molecular assay approved for use in transfusion medicine and the first to report genotypes as final results. To read the full story....

Progenika Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Progenika Rank

Progenika Frequently Asked Questions (FAQ)

  • Where is Progenika's headquarters?

    Progenika's headquarters is located at 500 Technology Square 1St Floor, Cambridge.

  • What is Progenika's latest funding round?

    Progenika's latest funding round is Other Investors.

  • Who are the investors of Progenika?

    Investors of Progenika include Boston University Technology Development.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.